NEWS
Corey Seager Holds the Veto on Any Rangers Trade
The Rangers will listen on Corey Seager at the GM meetings, but his new 10-and-5 rights mean the shortstop, not Texas, controls any deal before the lockout.
Chris Young told reporters in Las Vegas the Rangers are not under financial duress to dump Corey Seager, Jacob deGrom or Nathan Eovaldi. They will still listen on the 2023 World Series MVP, who is owed $155 million over five years and can now veto any trade.
Ken Rosenthal, citing people briefed on the club’s plans, said Texas intends to explore moving Seager at the meetings that opened Tuesday at the Aria. Young’s public line is cooler than that. The shortstop is the one who can turn either version into a deal, or into nothing.
Seager Now Holds a Full Trade Veto
Seager, 32, just finished his fifth season in Texas, which flipped a limited no-trade list into a full stop. He entered 2026 with 10.032 years of major league service. Five straight seasons with one club, on top of those 10 years, is the threshold. He can refuse a move to any team, not only the clubs that used to sit on his list.
Atlanta was already on that old eight-team list. deGrom, who has a contractual no-trade of his own, used his last summer to block a deal to the Braves. Seager now has the same kind of kill switch, earned under the labor deal rather than written into his contract. Scott Boras, his agent, will not treat that lightly.
THE 10-AND-5 RULE
- The threshold: Ten years of big league service and five straight with the same club.
- Seager’s status: He crossed both lines when 2026 ended, after five seasons in a Rangers uniform.
- The effect: He can refuse a trade to any of the other 29 teams, which means Texas is shopping a player who has to say yes.
That is why the GM meetings are a listening tour, not a closing room. Young can take offers. He cannot force Seager onto a plane.
Young’s Different Lens in Las Vegas
Young, the Rangers’ president of baseball operations, has spent two weeks saying the same thing in different rooms. Last week he talked about reshuffling cards and getting more athletic. On Tuesday in Las Vegas he said the club is very open-minded and looking through a different lens, then added that it does not mean a big deal is coming.
He also said the Rangers are not looking to trade anybody. They are exploring the market to make the 2027 roster better. Asked about Seager, deGrom and Eovaldi as a group, he said it does not have to be any of them, all of them, or two of them, and that Texas is not under financial duress to shed those contracts.
The more I script it right now, the less it’ll go according to that script as we go through the winter. I think the best thing we can do is to build a deep roster that has versatility. Some of that speaks to why we need to get younger, why we need to become more athletic and more dynamic, and have some of that versatility that we can spread across multiple positions.
Chris Young, Rangers president of baseball operations, before the GM meetings
That is the job description, not a teardown. Texas went 80-82 and missed the playoffs for a third straight year. Young wants 2027 payroll in the $190 million range, about where it sat in 2026. Center field became a primary need after Evan Carter had right hip surgery that will keep him out of the start of the season. The bullpen is being rebuilt from scratch for a third offseason. Catcher is thin. Young’s own phrasing is that clubs get younger, more athletic and more dynamic by trading one player and coming back stronger in two spots. Seager is the largest chip that could do that. He is also the one who has to approve it.
Five Years and $155 Million Still Due
Seager’s 10-year, $325 million contract began in 2022 and runs through 2031. The remaining money is $31 million a year for five seasons. That is the number a buyer has to swallow, or that Texas has to eat part of, in a three-week window before the labor deal dies.
deGrom is due $37 million in 2027, the last guaranteed year of his five-year, $185 million deal, with a club option for 2028. Eovaldi is due $20 million in 2027. Together the three are owed $88 million next season. Brandon Nimmo, acquired when Texas flipped Marcus Semien to the Mets, also controls his own destination. Moving any of them requires the player’s signature.
THE 2027 CHECKS TEXAS CANNOT MOVE ALONE
| Player | 2027 salary | Trade rights |
|---|---|---|
| Corey Seager | $31 million | 10-and-5 veto, earned after 2026 |
| Jacob deGrom | $37 million | Contract no-trade; blocked Atlanta at the deadline |
| Nathan Eovaldi | $20 million | Contract no-trade |
A Seager trade would clear more future money than moving deGrom, whose remaining guarantee is shorter. That is the front-office logic. The counter is simple. Five years at $31 million is a long bill for a shortstop who has not played 150 games since 2022, and who just had a bone spur taken out of his right elbow on October 9.
Walcott Makes the Shortstop Job Replaceable
Texas can even have this conversation because of Sebastian Walcott. He is the Rangers’ No. 1 prospect and No. 8 on MLB’s list, a 20-year-old shortstop listed at 6-foot-4 and 190 pounds, with a 2027 ETA. He is the reason a Seager deal does not have to be a hole at the most important infield spot. It can be a bet on the farm.
It is still a bet. Walcott had internal brace surgery in February after a torn ligament in his right elbow, a procedure the club framed as lighter than a full rebuild. He was in the Arizona Complex League by the All-Star break, in the Double-A Frisco lineup on July 17, and up to Triple-A Round Rock for two games in September. Club prospect notes put him at 10 home runs, 13 stolen bases and a.991 OPS in 41 minor league games. In the Arizona Fall League he has taken outfield reps because Josh Jung and Seager still block the left side if both stay.
HOW WALCOTT GOT TO THE DOORSTEP
- February: Internal brace on the right elbow after a torn UCL, with a five-to-six month window that he beat.
- July 17: Activated at Double-A Frisco and hit in the middle of a shortened season.
- September: Two games at Triple-A, then Fall League work that has included outfield, with a big league debut in 2027 still the plan.
Handing Opening Day to a prospect who turns 21 in March is a real risk, which is why Ezequiel Duran is the placeholder if Walcott is not ready. The payroll math still pulls Texas toward looking. If a Seager deal also brings a center fielder or bullpen help, Young gets the two-for-one he keeps describing. If Walcott is the shortstop and the $31 million is gone, the 2027 board looks different overnight.
Which Clubs Could Absorb the Contract?
A fit has to be a contender with a top-shelf payroll, a shortstop problem, and a willingness to carry $31 million a year through 2031, plus a destination Seager will accept. Rangers beat writer Evan Grant ran that filter and landed on three clubs: Atlanta, Boston and Philadelphia. High-payroll teams that need offense can line up behind them. The list shrinks again once Seager’s veto and a state-tax hit are in the room, because Texas does not levy income tax on that $31 million and several of those cities do.
He is still a shortstop other clubs would like on a good night. He is a two-time World Series MVP, from the 2020 Dodgers and the 2023 Rangers, a five-time All-Star, and a.284 career hitter with 241 home runs, 718 RBIs and 46.3 WAR in 12 seasons. From 2023 through 2025 he posted an OPS of.860 or higher each year. In 2023 he hit.327 with a 1.013 OPS and 7.2 WAR in only 119 games and finished second in AL MVP voting. The bat, when he plays, is not the question.
The 2026 season is. Seager played 102 games, the same total as in 2025, and hit.227/.312/.424 with 20 home runs, 51 RBIs and a.736 OPS. Baseball-Reference credited him with 3.1 WAR in 102 games, his lowest full Rangers season. He went on the injured list for lower back inflammation in May, a concussion in June, and the back again in July, then had the elbow cleaned out in October. He still started 95 games at shortstop. He has missed 202 games across 2023 through 2026.
SEAGER IN TEXAS, YEAR BY YEAR
| Season | Games | AVG / OPS | HR | WAR |
|---|---|---|---|---|
| 2022 | 151 | .245 /.772 | 33 | 3.8 |
| 2023 | 119 | .327 / 1.013 | 33 | 7.2 |
| 2024 | 123 | .278 /.864 | 30 | 5.2 |
| 2025 | 102 | .271 /.860 | 21 | 6.1 |
| 2026 | 102 | .227 /.736 | 20 | 3.1 |
That table is the scouting report a buyer has to live with. The 2023 MVP run is real. So is a 32-year-old coming off his worst offensive year, an elbow procedure, and a fifth straight season short of a full workload. In Texas he has 25.4 WAR in 597 games, with 137 home runs and an.849 OPS. The production is concentrated in fewer and fewer nights.
Atlanta, Boston and a Very Short List
Atlanta is the cleanest baseball match and the messiest human one. The Braves talked to Texas about deGrom in July and were willing to take on money. Mauricio Dubón, who led them in shortstop starts, is headed to free agency. They have already been told no by one Rangers star with a veto. Seager’s old list included them, and a move to Georgia would put state tax on a salary Texas does not tax. That is a quiet, practical reason for a 10-and-5 player to stay put, and it does not show up in a WAR chart.
Boston and Philadelphia pass the same payroll-and-need test. Boston looked at Seager last winter. Both play in markets that bring a louder spotlight than Arlington, which Grant has flagged as a possible turnoff. New York is in the same conversation among fans of the Yankees, who already have injury history on the infield and would be buying five years through Seager’s age-37 season. A reunion with the Dodgers makes for a clean headline and a hard payroll problem. None of those clubs can complete a deal Seager refuses.
Texas fans, in the replies to the first wave of reports, keep a simpler view. They want the 2023 postseason shortstop in a Rangers uniform. Young can say he is only taking temperature. That does not change how the room hears the rumor when the World Series MVP is the name on the board.
December 1 Stops the Clock on Any Deal
The labor deal expires at 11:59 p.m. ET on December 1. Owners are expected to lock players out after that, which would freeze trades, signings, and club contact with players until a new agreement is in place. The last lockout lasted 99 days. The Winter Meetings are set for San Diego on December 7-9 and would sit inside that freeze if the owners close the shop on time.
Owners want a salary cap. The league’s latest offer, on November 3, would delay a hard cap and floor until 2028, at $258.2 million and $180.2 million, and keep the current luxury-tax system for 2027. The union has rejected a cap in every form. Teams taking on $155 million do not know what the next labor deal will do to that money. That uncertainty is why Rosenthal called a Seager trade quite tricky even before the veto.
THE CALENDAR THAT HEMS THE MARKET IN
- October 9, 2026: Seager has a bone spur removed from his right elbow after a 102-game season.
- November 10-12, 2026: GM meetings at the Aria in Las Vegas, where Texas takes calls on Seager.
- December 1, 2026: The CBA expires at 11:59 p.m. ET; a lockout is expected to follow and halt trades.
So the market is a few weeks long, the player can kill any offer, and the next labor deal may punish the club that takes the contract. Young can keep saying he is not being forced to move anyone. He can also keep asking what Seager would bring back, because Walcott is close and the 2027 roster still needs a center fielder and a bullpen. The last word on all of that belongs to the shortstop who just earned the right to say no.
-
AUTO3 months agoThe Last Manual V-12 Lamborghini Cannot Come to America
-
BUSINESS3 months agoJBS’s Pilgrim’s Pride Bid Still Needs the 18 Percent
-
NEWS3 months agoRune Bets on Hillerød for His Achilles Comeback
-
NEWS3 months agoPermafrost Thaw Runs Fastest in Mountains, Not Arctic Soils
-
NEWS3 months agoMurphy Defends a British Open Title Nobody Keeps
-
BUSINESS3 months agoInfluencer Investors Trade Cash Fees for Illiquid Equity
-
NEWS3 months agoThe Roman Space Telescope Flies After Four Budget Fights
-
BUSINESS3 months agoRubicon Research Q1 Tests Its Specialty Pharma Bet
